Biotech specialized in precision medicine, our mission is to bring innovative therapeutic and diagnostic solutions to treat resistant and metastasis cancer.. .
Perfecto, tu título contiene entre 10 y 70 caracteres.
Genial, tu descripción meta contiene entre 70 y 160 caracteres.
Hemos encontrado 12 imágenes en esta web. 2 atributos alt están vacios o no existen. Agrega texto alternativo para que los motores de búsqueda puedan entender las imágenes.
Bien, el ratio entre texto y código HTML de esta página es mayor que 15, pero menor que 25 por ciento.
Perfecto, no se ha detectado contenido Flash en la página.
Genial, no se han detectado Iframes en la página.
| locale | en_GB |
|---|---|
| locale:alternate | fr_FR |
| type | website |
| title | Oncodesign Precision Medicine |
| description | Biotech specialized in precision medicine, our mission is to bring innovative therapeutic and diagnostic solutions to treat resistant and metastasis cancer. |
| url | http://www.oncodesign.com/ |
| site_name | Oncodesign Precision Medicine |
| image | https://www.oncodesign.com/wp-content/uploads/2022/09/oncodesign-pm-home-intro.png |
| image:width | 599 |
| image:height | 493 |
| image:type | image/png |
Enlaces Internos 95.83%
Enlaces Externos [Pasando Jugo 4.17%]
Enlaces Externos [noFollow 0%]
| Ancla | Link | Tipo | Jugo |
|---|---|---|---|
| Learn more | https://oncodesign-services.com/ | Externo | Pasando Jugo |
| Our pipeline | https://oncodesign.com/our-pipeline/ | Interna | Pasando Jugo |
| Partnering | https://oncodesign.com/our-pipeline/partnering/ | Interna | Pasando Jugo |
| Our innovation technologies | https://oncodesign.com/our-innovation-technologies/ | Interna | Pasando Jugo |
| OncoSNIPER | https://oncodesign.com/our-innovation-technologies/oncosniper/ | Interna | Pasando Jugo |
| Nanocyclix | https://oncodesign.com/our-innovation-technologies/nanocyclix/ | Interna | Pasando Jugo |
| PROMETHE | https://oncodesign.com/our-innovation-technologies/theranostics/ | Interna | Pasando Jugo |
| Investors | https://oncodesign.com/investors/ | Interna | Pasando Jugo |
| Message from the chairman | https://oncodesign.com/investors/message-from-the-chairman/ | Interna | Pasando Jugo |
| Regulated information [FR] | https://oncodesign.com/investors/regulated-information/ | Interna | Pasando Jugo |
| Press Release | https://oncodesign.com/press-release/ | Interna | Pasando Jugo |
| General Meetings [FR] | https://oncodesign.com/fr/investisseurs/assemblee-generale/ | Interna | Pasando Jugo |
| About us | https://oncodesign.com/about-us/ | Interna | Pasando Jugo |
| Latest news | https://oncodesign.com/about-us/news/ | Interna | Pasando Jugo |
| Our history | https://oncodesign.com/about-us/our-history/ | Interna | Pasando Jugo |
| Management | https://oncodesign.com/fr/a-propos/management-2/ | Interna | Pasando Jugo |
| Our HR policy | https://oncodesign.com/about-us/careers/ | Interna | Pasando Jugo |
| Our CSR approach | https://oncodesign.com/about-us/our-csr-approach/ | Interna | Pasando Jugo |
| FederAidd | https://oncodesign.com/about-us/federaidd/ | Interna | Pasando Jugo |
| Contact us | https://oncodesign.com/contact-us/ | Interna | Pasando Jugo |
| OPM announces a 6 million euros bank financing | https://oncodesign.com/opm-announces-a-6-million-euros-bank-financing/ | Interna | Pasando Jugo |
| OPM announces positive interim results of its Phase 1 study | https://oncodesign.com/opm-announces-positive-interim-results-of-its-phas | Interna | Pasando Jugo |
| Legal notice | https://oncodesign.com/legal-notice/ | Interna | Pasando Jugo |
| Personal data policy | https://oncodesign.com/personal-data-policy/ | Interna | Pasando Jugo |
| Palabra Clave (Keyword) | Contenido | Título | Palabras Claves (Keywords) | Descripción | Titulos |
|---|---|---|---|---|---|
| news | 5 |  |
|
|
 |
| therapeutic | 5 | |
|
|
|
| opm | 4 | |
|
|
|
| learn | 4 | |
|
|
|
| more | 4 | |
|
|
|
| innovative | 3 | |
|
|
|
| pipeline | 3 | |
|
|
|
| read | 3 | |
|
|
|
| innovation | 3 | |
|
|
|
| technologies | 3 | |
|
|
|
| oncodesign | 3 | |
|
|
|
| investors | 3 | |
|
|
|
14 Longitud
Perfecto. Has declarado como codificación UTF-8.
Genial. Has declarado el idioma EN. 
Genial, no hemos detectado ninguna etiqueta HTML obsoleta.
Genial, tu web tiene un favicon.
Genial. No hay ninguna dirección de email como texto plano!
Esta página no usa Dublin Core.
No hemos encontrado una hoja de estilos CSS para impresión.
newsletter, to find the best therapeutic path, our pipeline, our technologies, opm announces a 6 million euros bank financing, opm announces positive interim results of its phase 1 study, attention javascript est désactivé sur votre poste. ce site nécessite l'activation de javascript pour fonctionner correctement., our science, news, oncodesign precision medicine, opm, patient, benefit, announces, goals, activities, covering, precision, programs, drug, promethe, highly, latest, opportunities, october, attention, pipeline, technologies, policy, cro, nanocyclix, explore, shared, several, model, javascript, areas, discovery, investors, best--class, medicine, more, therapeutic, innovation, science, read, oncosniper, all, technological, solutions, newsletter, innovative, oncodesign, dedicated, learn, services, patients, first--class, news, also, oncodesign.com.
